Clinical trial
A Randomized, Controlled, Open-label Study to Evaluate the Efficacy of Smartphone Application in Patients With Type 2 Diabetes
NCT03468283 is registered in ClinicalTrials.gov with Kangbuk Samsung Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Controlled, Open-label Study to Evaluate the Efficacy of Smartphone Application in Patients With Type 2 Diabetes
- Lead sponsor
- Kangbuk Samsung Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 7, 2012
- Completion date
- March 13, 2013
- Enrollment
- 72 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.